Company profile
Cryo-Cell International, Inc.
AMEX: CCEL · Healthcare · Medical - Care Facilities
#498 of 1,422 Healthcare companies by revenue39th-percentile growth
EA Score
63CFH 67DQ 57GM 59SS 69
v0.1 · 65/100 weight · provisional
↑ growth stability, listing tenure · ↓ filing timeliness, balance-sheet leverage
Methodology →Revenue TTM
$31.3M
Rev growth YoY (TTM)
-2.6%
Net income (FY)
-$2.4M
Employees
74
as of 2026-08-20
Market cap
$32.8M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$31.6M$31.6M2025
Net income-$2.4M-$2.4M2025
Operating income$482.4k$482.4k2025
Total assets$61.7M$61.7M2025
Liabilities$80.3M$80.3M2025
Equity-$18.6M-$18.6M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Processing And Storage Fees99%
Public Banking0%
Product0%
By geography
FLORIDA100%
The read
What is Cryo-Cell International, Inc.’s revenue?
Cryo-Cell International, Inc. booked $31.6M in FY2025 revenue, contracting 1.3% year over year — slower than 61% of Healthcare companies we track, at a -7.7% net margin.
Peers · Healthcare
electroCore, Inc.57CNova Leap Health Corp.75B+Sonendo, Inc.——EyePoint Pharmaceuticals, Inc.58CVerastem, Inc.49DFoghorn Therapeutics Inc.47DNeighbors
Pinellas →Key facts
CEODavid Portnoy
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersOldsmar, FL
ExchangeAMEX: CCEL
Employees74
IPO date1994-04-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.